Suchergebnisse - "Curtin, Nicola"

PubPharm (127)

71

Poly(ADP-ribose) polymerase inhibitors in Ewing sarcoma

enthalten in: Current opinion in oncology | 2014

von Vormoor, B. | Curtin, N.

72

PARP inhibitors for anticancer therapy

enthalten in: Biochemical Society transactions | 2014

von Curtin, N.

73

DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin

enthalten in: Breast cancer research and treatment | 2014

von Ciszewski, W. | Tavecchio, M. | Dastych, J. | +1

74

PARP inhibitors target ATM+p53-defective gastric cancer

enthalten in: Cell cycle (Georgetown, Tex.) | 2014

von Curtin, N.

CommentOn: Cell Cycle. 2014;13(13):2129-37. - PMID 24841718

75

The use of ovarian cancer cells from patients undergoing surgery to generate primary cultures capable of undergoing functional analysis

enthalten in: PloS one | 2014

von O Donnell, R. | McCormick, A. | Mukhopadhyay, A. | +9

76

Therapeutic applications of PARP inhibitors : anticancer therapy and beyond

enthalten in: Molecular aspects of medicine | 2013

von Curtin, N. | Szabo, C.

77

DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin

enthalten in: Breast cancer research and treatment | 2013

von Ciszewski, W. | Tavecchio, M. | Dastych, J. | +1

78

DNA-PK inhibition by NU7441 sensitizes breast cancer cells to ionizing radiation and doxorubicin

enthalten in: Breast cancer research and treatment | 2013

von Ciszewski, W. | Tavecchio, M. | Dastych, J. | +1

79

Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer

enthalten in: Breast cancer research : BCR | 2013

von Eccles, S. | Aboagye, E. | Ali, S. | +84

CommentIn: Breast Cancer Res. 2013;15(5):107. - PMID 24172128

80

Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer

enthalten in: Breast cancer research | 2013

von Eccles, S. | Aboagye, E. | Ali, S. | +84